This trial is evaluating whether Treatment will improve 2 primary outcomes, 10 secondary outcomes, and 1 other outcome in patients with Tobacco Smoking Behavior. Measurement will happen over the course of Baseline, 12 months.
This trial requires 6220 total participants across 1 different treatment groups
This trial involves a single treatment. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Recent findings suggests that the prevalence of tobacco smoking behavior among youth who are smokers in the United States is significantly lower than in several other industrialized nations. Recent findings is the first to demonstrate the association between tobacco smoking and mental health.
Approximately 100,000 adolescents try to smoke cigarettes at some point in their life. Half of this subgroup will experience a regular smoking habit. The remaining 50% will be current or former smokers, but they will diminish their consumption at some point in their life. Overall, approximately 40% will try smoking tobacco regularly and approximately 20% will be regular smokers.
The study provides no evidence on whether tobacco smoking behavior can be cured, but indicates that smoking can be managed to reduce smoking-related health loss.
Tobacco smoking behavior in general and more specific behavior such as binge drinking and tobacco smoking during a specific day are associated with negative social and economic effects.
Tobacco smoking can result from a variety of internal and external influences, and these factors vary during childhood. Smoking prevention would focus on reducing exposure to peers and family, with additional support for cessation services during adolescence.
The evidence supports the view that brief interventions can improve behavior change outcomes and can be effective in smokers who are either abstinent or are only slightly nicotine dependent. In addition, smoking cessation can result in improvement or stabilization of several chronic health conditions. Finally, there is good evidence that tailored telephone-enhanced quit lines, delivered by trained counselors, can encourage smokers to quit without being offered medications to help them quit.
The goal of tobacco treatment is to reduce the risk of cancer and to prolong life. To accomplish those goals, the tobacco industry is promoting a tobacco use culture that promotes habitual smoking through both nicotine analogues and nicotine-containing nicotine replacement therapies (nicotinic NRTs), such as nicotine patches, gum, and smoking cessation aids. The use of nNRT and nicotine PPRs for smoking cessation can be lifesaving and has been proven effective in clinical research. Although some have questioned whether there is an ethical issue concerning the use of nicotine NRTs for smoking cessation, the use of smoking cessation in these products has been proven successful in research and is widely accepted in the medical literature.
For many women with chronic tinnitus, there is no'standard' treatment. For some women, tinnitus is managed through counselling and relaxation techniques. Treatment may also include medication. The type, dosage and frequency of drug use depends on the side effects the medication causes and the individual tinnitus problem. There are more than 20 over-the-counter medications available to help some tinnitus cases, and only nine that work for most people. It is easy to obtain your prescriptions from a local chemist or pharmacy, but you do not usually need to take them as prescribed. This is a summary of the treatment regimes used in the two clinical studies.
This preliminary study suggests that a 12-week smoking cessation program with intensive counseling is a successful and cost-effective option in improving the QOL of people who smoke.
The seriousness of tobacco smoking behavior in adolescents is significant. This should be taken into consideration during the tobacco health messages used for prevention and reduction of adolescent tobacco use.
Many individuals with a history of cigarette smoking should consider participation in clinical trials of potential treatments as a way to improve their smoking behavior.
There has been steady, recent growth in the tobacco industry and concerns about the negative effects of tobacco smoking on the health of people, especially on their children. This growth has been fueled by a combination of more marketing, less government interference, and a less regulated environment (including rising taxes on and other revenue loss from tobacco products). Because children tend to develop smoke tolerance, they are more sensitive to the addictiveness and the detrimental effects of more smoking, but they are less likely than adults to curtail their smoking; so the tobacco industry's efforts to attract new and adult customers are likely to have a more lasting impact. There is also a lack of reliable, comparative-control research on the behavioral effects of e-cigarette use in children and adolescents.